GlassScriptPhysician profile
J R Ross
NPI 1225084098
$490.28
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.35 · 2020: $38.91 · 2021: $99.52 · 2022: $183 · 2023: $30.57 · 2024: $42.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $134.28 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $72.57 | 2023-2024 | Gemtesa |
| Urovant Sciences INC | $70.00 | 2022 | |
| Pfizer INC. | $48.80 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $41.96 | 2022 | |
| Amgen INC. | $24.41 | 2022 | |
| Accord Healthcare, INC. | $18.91 | 2022 | |
| Gilead Sciences, INC. | $15.17 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $14.19 | 2021 | |
| Novo Nordisk INC | $13.44 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.32 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.02 | 2021 | |
| Therapeuticsmd, INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.